TLR9 and sarcoma: Interestingly, the response of p53/MCA sarcomas to CpG+RT was also diminished in TLR9+/– mice (Supplemental Figure 10C), suggesting that the level of TLR9 receptor plays a critical role in mediating the treatment response to CpG+RT (Supplemental Figure 10D).